This inventor holds 2 USPTO granted patents. Top assignee: The General Hospital Corporation. Active years: 1997-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1999
Title: David E Huizenga: Innovator in Catalytic DNA Technologies
Introduction
David E Huizenga is a notable inventor based in Winthrop, MA (US). He has made significant contributions to the field of molecular biology, particularly in the development of catalytic DNA technologies. With a total of 2 patents, Huizenga's work has the potential to impact various applications in biotechnology and medicine.
Latest Patents
Huizenga's latest patents include groundbreaking inventions. One of his patents is titled "Catalytic DNA having ligase activity." This invention features nucleic acid molecules, specifically DNA molecules, that possess catalytic activity. It also outlines methods for obtaining and utilizing these nucleic acid molecules. Another significant patent is focused on "DNA aptamers and catalysts that bind adenosine." This patent discloses single-stranded DNA molecules that bind adenosine or adenosine-5'-phosphate, along with methods for their production and isolation. Additionally, it covers methods for producing and isolating related catalytic DNA molecules.
Career Highlights
David E Huizenga is associated with The General Hospital Corporation, where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to the understanding of DNA's catalytic properties.
Collaborations
Huizenga has collaborated with esteemed colleagues, including Jack W Szostak and Bernard Cuenoud. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
David E Huizenga is a prominent figure in the field of catalytic DNA technologies. His innovative patents and collaborations highlight his commitment to advancing molecular biology. His contributions are poised to influence future developments in biotechnology and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
